Controversies in the management of asymptomatic carotid stenosis: from best medical therapy to a redefinition of surgical indications - Takeaways - MDSpire

Controversies in the management of asymptomatic carotid stenosis: from best medical therapy to a redefinition of surgical indications

  • By

  • Jianghao Zhou

  • Wei Zhu

  • Yong Lu

  • Huiming Dou

  • Guochu Peng

  • Changyang Zhong

  • July 2, 2026

  • 0 min

Share

  • 1

    Asymptomatic carotid artery stenosis (aCAS) prevalence increases with aging, affecting 4.2-7.5% of individuals over 60 years.

  • 2

    Historical trials established carotid endarterectomy as a treatment option, showing a 5-year stroke risk reduction from 11.0% to 5.1%.

  • 3

    Contemporary best medical therapy includes advanced lipid-lowering strategies and improved vascular risk factor control.

  • 4

    Recent trials challenge the reliance on luminal stenosis for intervention, emphasizing multidimensional biological risk assessment.

  • 5

    An individualized precision-management framework based on multimodal biomarkers is proposed for managing aCAS.

Original Source(s)

Controversies in the management of asymptomatic carotid stenosis: from best medical therapy to a redefinition of surgical indications

  • by Jianghao Zhou, Wei Zhu, Yong Lu, Huiming Dou, Guochu Peng, Changyang Zhong

  • July 2, 2026

Related Content

Case Report: Recurrent cerebral embolism secondary to direct cardiac invasion by lung adenocarcinoma

Association of the hemoglobin glycation index with the large-artery atherosclerosis subtype in ischemic stroke: a dual-cohort study

Performance and usability of retrieval-augmented large language models for stroke patient and caregiver support